13. CNS TB
• Most common form is TB Meningitis
• Its incidence is 3%
• Overall incidence of CNS TB is 1%
• Mostof the time it is associated with primary
TB
• Most common route of spread is Lympho-
Haematogenous
• Morbidity and Mortality is high.
15. Symptoms
• Age of presentation – at any age
• More common between 3 to 5 years (80%)
• Onset is subacute to chronic
• Clinical manifestation- Three Stages
16. Stage 1
• Prodromal stage (2-3 weeks)
• Non specific symptoms
Irritability, Letharginess, Sleep disturbance
Fatiguability, Headache, Vomiting
25. Symptoms and Signs
• Headache,irritability,lethargy,sleepiness
• Fever, nausea, vomiting, headache
• Seizures, Altered consciousness, abnormal
behaviour
• Fast - noisy breathing, visual disturbance
development of squint, angle of mouth,
difficult speech
• Weakness in limbs/difficult gait
26. • Hydrocephalus- increase in size of head ( > 3
SD), Sun set Sign, prominent viens over head.
• Fast Breathing Stridor – Raised ICT
• Meningeal irritation – Brudzinski and kernigs
• Cranial Nerve deficits
36. Treatment Goals
• To ensure early recovery
• Minimize the neurodeficit and sequelae
• To prevent transmission
• To start antitubercular treatment and
prevention of drug resistant
• Involve other department ( Neurosurgery,
Optha, Ent, physiotherapy whenever required)
37. Medical Management
• Needs hospitalization for prolonged period
• To kill bacteria and to prevent drug resistant
4 Drugs (HRZE) for 2 months
2 Drugs (HR) For 10 months
• To reduce inflammation, edema, vasculitis
Steroids for 6 weeks followed by tapering
38. • Intracranial Hypertension to be managed
using – mannitol , glycerol and 3% Nacl
• Seizures – According to the Cause
PHENOBARBITONE NOT TO BE USED
• Hydrocephalus
Acetazolamide to reduce CSF production
CSF Shunts
40. • Tuberculoma is a cluster of micro granulomas
which coalesce into mature non-caseating
granulomas in any organ
• Single lesion is common than multiple
• Located at any site, can be supratentorial or
infratentorial
41. Presentation
• Siezures usually partial type
• Without signs of meningeal irritation
• Neurodeficit – paresis, plegias
• Raised ICT usually present due to mass effect
• Symptoms as per the location-
Brain stem syndromes
Cerebellitis
43. Clinical Criteria
• Seizure should be initial symptom
• No features of persistent raised ICT
• No h/o progressive neurodeficit
• No h/o active systemic disease
Radiological Criteria
• Will be discussed with NCC
45. Prevalance
• Most common infection of CNS by parasites.
• Most frequent preventable cause of epilepsy
• Affects 50 million people worldwide.
• 50,000 deaths in highly endemic places.
46. Epidemic factors
– Egg contamination of grass and soil
– Method of raising domestic animals
– Unhygienic dinning habit of eating raw or
undercooked meat
49. CLINICAL SIGNS
• Acute symptomatic seizures are the most
common manifestation of human NCC;
• The other clinical conditions include –
headache, hydrocephalus, chronic meningitis,
focal neurological deficits, psychological
disorders, dementia
• Ocular symptoms- pain,blurring,vision loss
50. DDX: Tuberculoma Versus Cysticercus
Granuloma
Cysticercus Granuloma
• Round in shape
• Cystic
• 20mm or less with ring
enhancement or visible
scolex
• Cerebral edema not
enough to produce
midline shift or focal
neurological deficit
Tuberculoma
• Irregular in shape
• Solid
• Greater than 20mm
• Associated with severe
perifocal edema and focal
neurological deficit
52. TREATMENT
• Praziquantel three doses of 25-30 mg/kg at 2-
hour intervals on a single day equally effective
to the 50mg/kg 8 hourly dose for 15 days.
• Albendazole 15mg/kg/day in 2 divided doses
for 1 week equally effective to the 15
mg/kg/day 12 hrly for 28 days.